Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ (14,946,821)	$ 11,798,612
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(98,297)	(39,703)
Realized investment gains, net	(7,174,507)	(1,113,698)
Change in fair value of equity securities	24,684,444	(14,787,631)
Amortization of cost of insurance acquired	186,213	193,977
Depreciation	156,652	323,406
Stock-based compensation	201,549	229,800
Charges for mortality and administration of universal life and annuity products	(1,583,889)	(1,619,743)
Interest credited to account balances	1,009,012	1,029,303
Change in accrued investment income	296,495	232,788
Change in reinsurance receivables	37,201	(61,726)
Change in policy liabilities and accruals	(1,943,479)	(772,518)
Change in income taxes receivable (payable)	3,153,812	612,616
Change in other assets and liabilities, net	(9,630,253)	3,839,857
Net cash used in operating activities	(5,651,868)	(134,660)
Proceeds from investments sold and matured:
Fixed maturities available for sale	8,626,339	2,023,974
Equity securities	13,350,043	33,075
Mortgage loans	61,847	1,945,760
Real estate	1,119,842	3,045,226
Notes receivable	2,189,408	1,537,984
Policy loans	387,870	410,831
Short-term investments	3,000,000	0
Total proceeds from investments sold and matured	28,735,349	8,996,850
Cost of investments acquired:
Fixed maturities available for sale	(9,038,928)	0
Equity securities	(3,547,593)	(46,509)
Mortgage loans	(931,378)	(3,575,500)
Real estate	0	(1,174,688)
Notes receivable	(3,500,000)	(4,416,008)
Policy loans	(316,675)	(324,587)
Short-term investments	(7,890,228)	0
Total cost of investments acquired	(25,224,802)	(9,537,292)
Net cash provided by (used in) investing activities	3,510,547	(540,442)
Cash flows from financing activities:
Policyholder contract deposits	1,187,672	1,264,011
Policyholder contract withdrawals	(1,092,331)	(1,231,379)
Purchase of treasury stock	(310,603)	(212,387)
Non controlling contributions (distributions) of consolidated subsidiary	0	(245,750)
Net cash used in financing activities	(215,262)	(425,505)
Net decrease in cash and cash equivalents	(2,356,583)	(1,100,607)
Cash and cash equivalents at beginning of period	28,787,629	20,150,162
Cash and cash equivalents at end of period	$ 26,431,046	$ 19,049,555